Humacyte (HUMA) Change in Acquisitions & Divestments (2022)
Humacyte (HUMA) reported Change in Acquisitions & Divestments of $8.0 million for Q4 2022.
Humacyte (HUMA) Change in Acquisitions & Divestments (2022) Analysis & Trends
Humacyte (HUMA) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $8.0 million in Q4 2022.
- Change in Acquisitions & Divestments for Q4 2022 came in at $8.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $8.0 million (changed 0.0% YoY), and the FY2023 annual result was $2.1 million, down 86.83% from the prior year.
- Change in Acquisitions & Divestments steadied at $8.0 million in Q4 2022 per HUMA's latest filing.
- Over five years, Change in Acquisitions & Divestments peaked at $8.0 million in Q4 2022 and troughed at $8.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 8.00 Mn |
| Dec 31, 2022 | 8.00 Mn |